Neuroadaptations in human chronic alcoholics: dysregulation of the NF-kappaB system.
- Authors
- Okvist, Anna; Johansson, Sofia; Kuzmin, Alexander; Bazov, Igor; Merino-Martinez, Roxana; Ponomarev, Igor; Mayfield, R Dayne; Harris, R Adron; Sheedy, Donna; Garrick, Therese; Harper, Clive; Hurd, Yasmin L; Terenius, Lars; Ekström, Tomas J; Bakalkin, Georgy; Yakovleva, Tatjana
- Year
- 2007
- Journal
- PloS one
- PMID
- 17895971
- DOI
- 10.1371/journal.pone.0000930
- PMCID
- PMC1976556
BACKGROUND: Alcohol dependence and associated cognitive impairments apparently result from neuroadaptations to chronic alcohol consumption involving changes in expression of multiple genes. Here we investigated whether transcription factors of Nuclear Factor-kappaB (NF-kappaB) family, controlling neuronal plasticity and neurodegeneration, are involved in these adaptations in human chronic alcoholics. METHODS AND FINDINGS: Analysis of DNA-binding of NF-kappaB (p65/p50 heterodimer) and the p50 homodimer as well as NF-kappaB proteins and mRNAs was performed in postmortem human brain samples from 15 chronic alcoholics and 15 control subjects. The prefrontal cortex involved in alcohol dependence and cognition was analyzed and the motor cortex was studied for comparison. The p50 homodimer was identified as dominant kappaB binding factor in analyzed tissues. NF-kappaB and p50 homodimer DNA-binding was downregulated, levels of p65 (RELA) mRNA were attenuated, and the stoichiometry of p65/p50 proteins and respective mRNAs was altered in the prefrontal cortex of alcoholics. Comparison of a number of p50 homodimer/NF-kappaB target DNA sites, kappaB elements in 479 genes, down- or upregulated in alcoholics demonstrated that genes with kappaB elements were generally upregulated in alcoholics. No significant differences between alcoholics and controls were observed in the motor cortex. CONCLUSIONS: We suggest that cycles of alcohol intoxication/withdrawal, which may initially activate NF-kappaB, when repeated over years downregulate RELA expression and NF-kappaB and p50 homodimer DNA-binding. Downregulation of the dominant p50 homodimer, a potent inhibitor of gene transcription apparently resulted in derepression of kappaB regulated genes. Alterations in expression of p50 homodimer/NF-kappaB regulated genes may contribute to neuroplastic adaptation underlying alcoholism.
WB images of p65, p50 and IKKβ proteins in the PFC.Representative blots of three control subjects (c) and three alcoholics (a).
Stoichiometry of p65/p50 and IKKβ/p65 proteins (A), and RELA/NFKB1 and IKKβ/RELA mRNAs (B).Results are presented for the PFC of alcoholics (n = 15) and control subjects (n = 15) as mean±SD. Significance of differences between groups was evaluated by Mann Whitney U-test (A, p65/p50), covariance by multiple regression analysis (A, IKKβ/p65, covariate age; age×group interaction), or Student's t-test (B). * P<0.05.
κB–binding factors in the PFC identified by EMSA.(A) The constitutively active κB-DNA binding activity was determined by incubation of tissue extracts with labeled κB-oligonucleotide followed by treatment with 0.03% DOC solution (DOC-) that did not affect DNA-protein complex formation and was used as a control. Latent factors were activated for binding to DNA by treatment with 0.6% DOC (DOC+) that dissociated IκB inhibitory protein from complexes with NF-κB, thus allowing to measure the total DNA-binding. Total NF-κB activity consisted of the constitutively active and DOC-activated DNA binding activities. The specificity of DNA-protein complexes was assessed by competition with wild type-κB (wt) or mutant-κB (m) oligonucleotides. Upper sequence-specific complexes I and II consisted of NF-κB and p50 homodimer, respectively, as demonstrated previously [24], [47]. The lower complex III showed no DNA-binding sequence specificity and was probably formed by Ku protein [48], [49]. For the upper image, film was exposured with a gel for longer time than for the lower one. (B) Representative picture of the constitutively active (DOC-) and total (DOC+) κB–binding activities in the PFC of control subjects and alcoholics. Lanes 3 (subject 13C) and 15 (subject 3A), only weak or no complexes were formed (see Table 1 for the description of subjects).
Correlations between DNA-binding activity, protein and mRNA levels.(A) Constitutively active NF-κB DNA binding correlates with IKKβ protein levels in the PFC of alcoholics (n = 13; P = 0.002) and control subjects (n = 11; P = 0.007). No significant difference was found between slopes in the alcohol and control group. (B) p65 and p50 protein levels (15 control subjects: P = 0.01; 15 alcoholics: P = 0.06) and (C) RELA and NFKB1 mRNA levels (15 control subjects: P<0.0001; 15 alcoholics: P<0.0002) correlate in the PFC.
κB elements in genes differentially expressed in alcoholics.Frequencies of occurrence of the “NF-κB”- and “p50 homodimer”-subtypes of κB binding sites in 270 and 209 genes downregulated and upregulated in alcoholics, respectively, and 1164 control genes (Table S1). (A,B) Matrices from the JASPAR database (http://mordor.cgb.ki.se/cgi-bin/jaspar2005/jaspar_db.pl) used to identify “NF-κB” (A) and “p50 homodimer” (B) subtypes of κB binding sites. Both NF-κB and p50 homodimer bind to the “NF-κB” subtype of κB elements with high affinity and specificity whereas p50 homodimer has higher affinity for more symmetric “p50 homodimer”-subtype of κB binding sites [51], [52]. The matrix logos provide visual representation profiles of nucleotide conservation in κB elements. The maximal conservation amounts are 2 bits for each position. Higher conservation indicates increased biological importance for a base. (C, D). Frequencies of occurrence of the “NF-κB”- (C) and “p50 homodimer”- (D) subtypes of κB binding sites in 270 and 209 genes downregulated and upregulated in alcoholics, respectively, and in 1164 control genes (Table S1). Significance of differences between upregulated, downregulated and control genes in the frequency of occurrence of genes with κB elements were evaluated with Chi-square test (df = 2). Pairwise comparison of the up- with downregulated genes, the upregulated with control genes, and the downregulated with control genes was performed with Chi Square test (df = 1). ** P<0.01, * P<0.05.
Model for the molecular adaptations in the NF-κB system in the PFC in alcoholics.(A) Chronic alcohol intake inhibits RELA gene transcription and induces alterations in stoichiometry of RELA/NFKB1 mRNAs and p65/p50 proteins, resulting in downregulation of NF-κB DNA-binding. In cells with dominant NF-κB this adaptation results in inhibition of NF-κB-dependent transcription. (B) Alcohol acts upstream of an unidentified protein kinase that modulates DNA-binding of the p50 homodimer. This results in hypophosphorylation of p50 and downregulation of p50 homodimer DNA-binding. In control individuals the p50 homodimer inhibits gene transcription acting through κB binding sites in cells in which it prevails over NF-κB. In alcoholics, downregulation of the p50 homodimer eliminates transcriptional repression leading to upregulation of κB-mediated transcription. Dysregulation of the NF-κB/p50 homodimer-dependent gene transcription contributes to cellular neuroplastic adaptations and neurodegeneration.
| Name | Type |
|---|---|
| 32P-labeled oligonucleotide local | drug |
| acetic acid | drug |
| ACTB | gene |
| age | phenotype |
| Agilent 2100 Bioanalyzer | drug |
| alcohol | phenotype |
| alcohol abuse | phenotype |
| alcohol dependence | phenotype |
| alcoholic group | cohort |
| alcohol intoxication | phenotype |
| alcoholism | phenotype |
| Alcohol-preferring mouse genotype local | cohort |
| Alcohol toxicity | phenotype |
| Alcohol Use Disorder | phenotype |
| alcohol withdrawal | phenotype |
| amygdala | anatomy |
| Applied Biosystems 7900HT Fast Real-Time PCR System local | drug |
| brain | anatomy |
| brain pH | phenotype |
| brain tissue pH local | phenotype |
| Brodmann area 9 | anatomy |
| BSA | drug |
| Buffer C local | drug |
| calcium influx local | drug |
| cDNA | drug |
| Cell loss local | phenotype |
| cerebellar extracts local | drug |
| cerebellum | anatomy |
| chronic alcoholism | phenotype |
| chronic neurodegenerative disorders local | phenotype |
| CHUK local | gene |
| cocaine | phenotype |
| cognition | phenotype |
| Collaborative Study on the Genetics of Alcoholism (COGA) | cohort |
| Complete local | drug |
| Complex I local | drug |
| Complex II local | drug |
| Complex III local | drug |
| control | cohort |
| control genes local | gene |
| control group | cohort |
| controls | cohort |
| control set local | cohort |
| control subjects | cohort |
| craving | phenotype |
| CREB1 | gene |
| cytokines | drug |
| Damage to hippocampus local | phenotype |
| Damage to prefrontal cortex local | phenotype |
| Daxx | gene |
| DC protein assay local | drug |
| Deficits in abstraction local | phenotype |
| Deficits in perceptual-motor skills local | phenotype |
| Deficits in problem solving local | phenotype |
| Deficits in visual-spatial functions local | phenotype |
| deoxycholate local | drug |
| developmental cell death local | phenotype |
| DFFA local | gene |
| differentially expressed genes | gene |
| DNA-binding complexes local | drug |
| DOC local | drug |
| drug dependence | phenotype |
| DTT | drug |
| ECL detection system local | drug |
| EDTA | drug |
| ethanol consumption | phenotype |
| fear conditioning | phenotype |
| Fosb | gene |
| glucocorticoid receptors local | gene |
| glutamate | drug |
| glutamate receptors local | drug |
| glycerol | drug |
| glycine | drug |
| Goat anti-rabbit antibody local | drug |
| Goat polyclonal antibody local | drug |
| heavy drinking | phenotype |
| HEPES | drug |
| High Capacity cDNA Archive Kit local | drug |
| Hippocampal neuron shrinkage local | phenotype |
| Hippocampal volume | anatomy |
| hippocampus | anatomy |
| histone deacetylases (HDAC) local | drug |
| horseradish peroxidase | drug |
| human alcoholics | phenotype |
| human brain | anatomy |
| Human chronic alcoholics local | cohort |
| human PFC local | anatomy |
| human postmortem brain samples local | cohort |
| hyperglutamatergic state | phenotype |
| IKBKB | gene |
| IKBKG local | gene |
| IKK complex local | gene |
| IKKβ local | drug |
| IKKβ | gene |
| Immunodeficiency virus enhancer local | gene |
| Increased drinking local | phenotype |
| IκB local | gene |
| IκB inhibitory protein local | drug |
| KCl | drug |
| Klenow enzyme local | drug |
| Ku local | drug |
| Ku protein local | drug |
| Ku protein local | gene |
| Liver cirrhosis | phenotype |
| low brain pH local | phenotype |
| LTP/LTD local | phenotype |
| MBP | gene |
| MC local | cohort |
| Memcode Reversible Protein Stain Kit local | drug |
| methanol | drug |
| MG132 local | drug |
| MgCl2 | drug |
| motor cortex | anatomy |
| mRNA | drug |
| mutant κB fragment local | variant |
| m-κB local | variant |
| m-κB oligonucleotide local | drug |
| Nanodrop | drug |
| neuroadaptation | phenotype |
| Neurocognitive deficits | phenotype |
| neurodegeneration | phenotype |
| neuroinflammation | phenotype |
| Neuronal excitation local | phenotype |
| NFKB1 | gene |
| NFKBIA | gene |
| NFKBIB local | gene |
| NF-κB | gene |
| NFκB | gene |
| NF-κB/p50 local | gene |
| NF-κB/p50 homodimer local | drug |
| NF-κB (p50/p65 heterodimer) local | gene |
| NF-κB signaling pathway local | drug |
| nitrocellulose membranes | drug |
| Nonpreferring mouse genotype local | cohort |
| NOS2 | gene |
| NP-40 | drug |
| nucleus accumbens | anatomy |
| oxidative processes local | drug |
| oxidative stress | phenotype |
| P32 local | drug |
| p50 local | drug |
| p50 homodimer local | drug |
| p65 local | drug |
| p65 local | gene |
| PFC | anatomy |
| PKA | drug |
| Poly drug abuse local | phenotype |
| postmortem brain | anatomy |
| postmortem interval | phenotype |
| prefrontal cortex | anatomy |
| protease | drug |
| protease inhibitors | drug |
| proteasome local | drug |
| protein | drug |
| protein extracts local | drug |
| protein kinase A | drug |
| PTGS2 | gene |
| Rabbit anti-goat antibody local | drug |
| Rabbit polyclonal antibody local | drug |
| rat brain tissues local | cohort |
| REL local | gene |
| RELA local | gene |
| relapse | phenotype |
| RELB local | gene |
| RNA | drug |
| RNeasy Mini kit | drug |
| RPLP0 | gene |
| rRNA | drug |
| SDS | drug |
| smoking status | phenotype |
| SP-1 local | gene |
| spatial memory | phenotype |
| Stripping buffer local | drug |
| superior frontal cortex | anatomy |
| TaqMan Low Density Arrays local | drug |
| TaqMan Universal PCR Master Mix | drug |
| Tissue Resource Center, University of Sydney local | cohort |
| TNF | gene |
| TNFRSF1A | gene |
| TP53 | gene |
| Tris-HCl | drug |
| ventral tegmental area | anatomy |
| voluntary alcohol consumption | phenotype |
| Wernicke–Korsakoff syndrome local | phenotype |
| white matter | anatomy |
| wild type κB fragment local | variant |
| wt-κB local | variant |
| wt-κB oligonucleotide local | drug |
| β-mercaptoethanol | drug |
| ΔFosB | gene |
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Naltrexone Alters Neurochemical and Behavioral Parameters in a Zebrafish Model of Repeated Alcohol Exposure. | Bernardo HT et al. | — | 2025 | → |
| The Neuropathology of Alcohol Use Disorder: Cellular Insights From Human Post-Mortem Studies. | Rasool AE et al. | — | 2025 | → |
| Influence of sex and liver cirrhosis on the expression of miR-146a-5p and its target genes, IRAK1 and TRAF6. | Naidu C et al. | — | 2024 | → |
| The neuroimmune system - Where aging and excess alcohol intersect. | Carlson ER et al. | — | 2023 | → |
| Mass Spectrometry-Based Proteome Profiling of Extracellular Vesicles Derived from the Cerebrospinal Fluid of Adult Rhesus Monkeys Exposed to Cocaine throughout Gestation. | Rather HA et al. | — | 2022 | → |
| Behavioral and Gene Regulatory Responses to Developmental Drug Exposures in Zebrafish. | Mech AM et al. | — | 2021 | → |
| Predictive values of tumor necrosis factor-α for depression treatment outcomes: effect modification by hazardous alcohol consumption. | Choi W et al. | — | 2021 | → |
| Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages. | Nolan RA et al. | — | 2020 | → |
| Intermittent Ethanol Access Increases Sensitivity to Social Defeat Stress. | Nennig SE et al. | — | 2020 | → |
| Relationship of Wine Consumption with Alzheimer's Disease. | Reale M et al. | — | 2020 | → |
| Tumour Necrosis Factor in Neuroplasticity, Neurogenesis and Alcohol Use Disorder. | Alvarez Cooper I et al. | — | 2020 | → |
| Associations of <i>BRAP</i> polymorphisms with the risk of alcohol dependence and scores on the Alcohol Use Disorders Identification Test. | Kim JW et al. | — | 2019 | → |
| Its complicated: The relationship between alcohol and microglia in the search for novel pharmacotherapeutic targets for alcohol use disorders. | Melbourne JK et al. | — | 2019 | → |
| Toll-like receptor 3 activation increases voluntary alcohol intake in C57BL/6J male mice. | Warden AS et al. | — | 2019 | → |
| Alcohol-Mediated Organ Damages: Heart and Brain. | Obad A et al. | — | 2018 | → |
| Innate Immune Signaling and Alcohol Use Disorders. | Coleman LG et al. | — | 2018 | → |
| Peripheral TNFα elevations in abstinent alcoholics are associated with hepatitis C infection. | Zahr NM | — | 2018 | → |
| Persistent Adult Neuroimmune Activation and Loss of Hippocampal Neurogenesis Following Adolescent Ethanol Exposure: Blockade by Exercise and the Anti-inflammatory Drug Indomethacin. | Vetreno RP et al. | — | 2018 | → |
| Transcriptional Regulators as Targets for Alcohol Pharmacotherapies. | Savarese AM et al. | — | 2018 | → |
| Changes in Pro-Inflammatory Markers in Detoxifying Chronic Alcohol Abusers, Divided by Lesch Typology, Reflect Cognitive Dysfunction. | Hanak C et al. | — | 2017 | → |
| Gene expression profiling in the human alcoholic brain. | Warden AS et al. | — | 2017 | → |
| The role of neuroimmune signaling in alcoholism. | Crews FT et al. | — | 2017 | → |
| The Role of NFkB in Drug Addiction: Beyond Inflammation. | Nennig SE et al. | — | 2017 | → |
| Toll-like receptor signaling and stages of addiction. | Crews FT et al. | — | 2017 | → |
| Alcohol abuse after traumatic brain injury: Experimental and clinical evidence. | Weil ZM et al. | — | 2016 | → |
| Ethanol-Induced Neurodegeneration and Glial Activation in the Developing Brain. | Saito M et al. | — | 2016 | → |
| Inhibition of IKKβ Reduces Ethanol Consumption in C57BL/6J Mice. | Truitt JM et al. | — | 2016 | → |
| Mechanisms of neuroimmune gene induction in alcoholism. | Crews FT et al. | — | 2016 | → |
| The neuroimmune transcriptome and alcohol dependence: potential for targeted therapies. | Warden A et al. | — | 2016 | → |
| The NSW brain tissue resource centre: Banking for alcohol and major neuropsychiatric disorders research. | Sutherland GT et al. | — | 2016 | → |
| Matching Diabetes and Alcoholism: Oxidative Stress, Inflammation, and Neurogenesis Are Commonly Involved. | Barcia JM et al. | — | 2015 | → |
| Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans. | Blednov YA et al. | — | 2015 | → |
| Association study of DKK2 polymorphisms with alcohol dependence and alcohol-related harm. | Kim JY et al. | — | 2014 | → |
| Current hypotheses on the mechanisms of alcoholism. | Vetreno RP et al. | — | 2014 | → |
| Fetal alcohol spectrum disorders and neuroimmune changes. | Drew PD et al. | — | 2014 | → |
| Neuroimmune basis of alcoholic brain damage. | Crews FT et al. | — | 2014 | → |
| Neuroimmune pathways in alcohol consumption: evidence from behavioral and genetic studies in rodents and humans. | Robinson G et al. | — | 2014 | → |
| Neuropathology of alcoholism. | Sutherland GT et al. | — | 2014 | → |
| Mu-opioid signaling modulates biphasic expression of TrkB and IκBα genes and neurite outgrowth in differentiating and differentiated human neuroblastoma cells. | Wen A et al. | — | 2013 | → |
| Neuroimmune signaling: a key component of alcohol abuse. | Mayfield J et al. | — | 2013 | → |
| Positively correlated miRNA-mRNA regulatory networks in mouse frontal cortex during early stages of alcohol dependence. | Nunez YO et al. | — | 2013 | → |
| A longitudinal analysis of circulating stress-related proteins and chronic ethanol self-administration in cynomolgus macaques. | Helms CM et al. | — | 2012 | → |
| Immune function genes, genetics, and the neurobiology of addiction. | Crews FT | — | 2012 | → |
| Neuroimmune mechanisms in fetal alcohol spectrum disorder. | Kane CJ et al. | — | 2012 | → |
| Protracted abstinence from distinct drugs of abuse shows regulation of a common gene network. | Le Merrer J et al. | — | 2012 | → |
| TLR4-MyD88 signalling: a molecular target for alcohol actions. | Pandey SC | — | 2012 | → |
| Understanding Alcoholism Through microRNA Signatures in Brains of Human Alcoholics. | Nunez YO et al. | — | 2012 | → |
| Addiction, adolescence, and innate immune gene induction. | Crews FT et al. | — | 2011 | → |
| Importance of genetic background for risk of relapse shown in altered prefrontal cortex gene expression during abstinence following chronic alcohol intoxication. | Hashimoto JG et al. | — | 2011 | → |
| Induction of innate immune genes in brain create the neurobiology of addiction. | Crews FT et al. | — | 2011 | → |
| Prodynorphin promoter SNP associated with alcohol dependence forms noncanonical AP-1 binding site that may influence gene expression in human brain. | Taqi MM et al. | — | 2011 | → |
| The inflammatory footprints of alcohol-induced oxidative damage in neurovascular components. | Alikunju S et al. | — | 2011 | → |
| Transcriptional control of maladaptive and protective responses in alcoholics: a role of the NF-κB system. | Yakovleva T et al. | — | 2011 | → |
| Alcohol and the prefrontal cortex. | Abernathy K et al. | — | 2010 | → |
| A systematic gene-based screen of chr4q22-q32 identifies association of a novel susceptibility gene, DKK2, with the quantitative trait of alcohol dependence symptom counts. | Kalsi G et al. | — | 2010 | → |
| Genome-wide gene expression analysis identifies K-ras as a regulator of alcohol intake. | Repunte-Canonigo V et al. | — | 2010 | → |
| Induction of innate immune gene expression cascades in brain slice cultures by ethanol: key role of NF-κB and proinflammatory cytokines. | Zou J et al. | — | 2010 | → |
| Prodynorphin mutations cause the neurodegenerative disorder spinocerebellar ataxia type 23. | Bakalkin G et al. | — | 2010 | → |
| Reduced nucleus accumbens SK channel activity enhances alcohol seeking during abstinence. | Hopf FW et al. | — | 2010 | → |
| Impulsivity, frontal lobes and risk for addiction. | Crews FT et al. | — | 2009 | → |
| The importance of brain banks for molecular neuropathological research: The New South Wales Tissue Resource Centre experience. | Dedova I et al. | — | 2009 | → |
| Alcohol-related neurodegeneration and recovery: mechanisms from animal models. | Crews FT | — | 2008 | → |
| An Australian Brain Bank: a critical investment with a high return! | Sheedy D et al. | — | 2008 | → |
| Elevated synaptophysin I in the prefrontal cortex of human chronic alcoholics. | Henriksson R et al. | — | 2008 | → |
| Modulation of voluntary ethanol consumption by beta-arrestin 2. | Björk K et al. | — | 2008 | → |